| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |